Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial
Crowley DC, Lau FC, Sharma P
Published in International Journal of Medical Sciences
Methodology
Randomized 90-day trial comparing UC-II 40 mg/day with glucosamine plus chondroitin in knee osteoarthritis
Key Findings
UC-II reduced WOMAC, VAS and Lequesne scores significantly more than glucosamine plus chondroitin
Conclusions
UC-II was more effective than glucosamine plus chondroitin for knee osteoarthritis symptoms
Limitations
No placebo arm; industry sponsored; moderate sample
Supplements Studied
UC-II reduced WOMAC, VAS and Lequesne scores more than glucosamine plus chondroitin
UC-II reduced WOMAC, VAS and Lequesne scores significantly more than glucosamine plus chondroitin
UC-II reduced WOMAC, VAS and Lequesne scores significantly more than glucosamine plus chondroitin
Outcomes Measured
UC-II reduced WOMAC, VAS and Lequesne pain scores more than glucosamine plus chondroitin
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.